CXCR4 and non-small cell lung carcinoma: It would be of interest to investigate the effects of CXCR4 inhibition in a NSCLC model system that recapitulates the entire spectrum of the metastatic process, whereby distant lesions originate from a primary subcutaneous or orthotopic site.